Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies

BackgroundNumerous observational studies have investigated the risk of prostate cancer (PCa) in patients diagnosed with Parkinson’s Disease (PD). However, the existence of a definitive association remains uncertain.MethodsSystematic searches were performed on PubMed, Web of Science, Scopus, and Goog...

Full description

Bibliographic Details
Main Authors: Li Wang, Jing-ya Deng, Xi-yue Fan, Dan Yang, Ping-yu Zhu, Xiao-ming Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1323812/full
_version_ 1797365983799672832
author Li Wang
Jing-ya Deng
Xi-yue Fan
Dan Yang
Ping-yu Zhu
Xiao-ming Wang
Xiao-ming Wang
author_facet Li Wang
Jing-ya Deng
Xi-yue Fan
Dan Yang
Ping-yu Zhu
Xiao-ming Wang
Xiao-ming Wang
author_sort Li Wang
collection DOAJ
description BackgroundNumerous observational studies have investigated the risk of prostate cancer (PCa) in patients diagnosed with Parkinson’s Disease (PD). However, the existence of a definitive association remains uncertain.MethodsSystematic searches were performed on PubMed, Web of Science, Scopus, and Google Scholar for studies published up to October 1, 2023. For Mendelian randomized (MR) causal inference, we employed pooled data from the IPDGC and PRACTICAL Consortium. The inverse variance weighted (IVW) method served as the principal technique for estimating odds ratios (ORs) and 95% confidence intervals (CIs) for the associations under investigation.ResultsCumulative analysis of nine studies revealed no significant association between patients diagnosed with PD and the subsequent incidence of PCa ([relative ratio] RR = 0.89, 95%CI = 0.73 to 1.08, P = 0.237). However, subgroup analyses indicated a reduced occurrence of PCa in Caucasian patients with PD (RR = 0.81, 95%CI = 0.69 to 0.95, P = 0.011). MR analyses failed to establish a significant link between increased genetic susceptibility to PD and the risk of PCa (IVW OR = 1.025, 95%CI = 0.997 to 1.054, P = 0.082). Sensitivity analyses further corroborated the robustness of these results.ConclusionBoth observational meta-analysis and MR analysis based on genetic variation do not support an association between PD patients and the subsequent risk of PCa. Further research is warranted to unravel the potential underlying mechanisms linking these two diseases.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42023473527.
first_indexed 2024-03-08T16:56:46Z
format Article
id doaj.art-4f63b9b4100745238953e6bd118e42a8
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-08T16:56:46Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-4f63b9b4100745238953e6bd118e42a82024-01-04T21:35:21ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-01-011310.3389/fonc.2023.13238121323812Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studiesLi Wang0Jing-ya Deng1Xi-yue Fan2Dan Yang3Ping-yu Zhu4Xiao-ming Wang5Xiao-ming Wang6Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Neurology, Institute of Neurological Diseases of North Sichuan Medical College, Sichuan, Nanchong, ChinaBackgroundNumerous observational studies have investigated the risk of prostate cancer (PCa) in patients diagnosed with Parkinson’s Disease (PD). However, the existence of a definitive association remains uncertain.MethodsSystematic searches were performed on PubMed, Web of Science, Scopus, and Google Scholar for studies published up to October 1, 2023. For Mendelian randomized (MR) causal inference, we employed pooled data from the IPDGC and PRACTICAL Consortium. The inverse variance weighted (IVW) method served as the principal technique for estimating odds ratios (ORs) and 95% confidence intervals (CIs) for the associations under investigation.ResultsCumulative analysis of nine studies revealed no significant association between patients diagnosed with PD and the subsequent incidence of PCa ([relative ratio] RR = 0.89, 95%CI = 0.73 to 1.08, P = 0.237). However, subgroup analyses indicated a reduced occurrence of PCa in Caucasian patients with PD (RR = 0.81, 95%CI = 0.69 to 0.95, P = 0.011). MR analyses failed to establish a significant link between increased genetic susceptibility to PD and the risk of PCa (IVW OR = 1.025, 95%CI = 0.997 to 1.054, P = 0.082). Sensitivity analyses further corroborated the robustness of these results.ConclusionBoth observational meta-analysis and MR analysis based on genetic variation do not support an association between PD patients and the subsequent risk of PCa. Further research is warranted to unravel the potential underlying mechanisms linking these two diseases.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42023473527.https://www.frontiersin.org/articles/10.3389/fonc.2023.1323812/fullParkinson’s diseaseprostate cancerMendelian randomizationgenetic variantsmeta-analysis
spellingShingle Li Wang
Jing-ya Deng
Xi-yue Fan
Dan Yang
Ping-yu Zhu
Xiao-ming Wang
Xiao-ming Wang
Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies
Frontiers in Oncology
Parkinson’s disease
prostate cancer
Mendelian randomization
genetic variants
meta-analysis
title Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies
title_full Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies
title_fullStr Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies
title_full_unstemmed Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies
title_short Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies
title_sort absence of causal relationship between parkinson s disease and subsequent prostate cancer evidence from meta analysis and mendelian randomization studies
topic Parkinson’s disease
prostate cancer
Mendelian randomization
genetic variants
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1323812/full
work_keys_str_mv AT liwang absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies
AT jingyadeng absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies
AT xiyuefan absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies
AT danyang absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies
AT pingyuzhu absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies
AT xiaomingwang absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies
AT xiaomingwang absenceofcausalrelationshipbetweenparkinsonsdiseaseandsubsequentprostatecancerevidencefrommetaanalysisandmendelianrandomizationstudies